(Press-News.org) DALLAS, March 21, 2023 — More than 2 million veterans are living with atherosclerotic cardiovascular disease (ASCVD) and require management of their high cholesterol, according to the Department of Veterans Affairs (VA). Left unaddressed, high cholesterol increases the chance of experiencing heart attack and stroke. To control high cholesterol among veterans, the American Heart Association, the world’s leading nonprofit organization focused on heart and brain health for all, in collaboration with the VA, has launched a new VA Medical Center program to help former service members with ASCVD who are at high risk of cardiovascular events.
ASCVD is caused by plaque buildup in arterial walls and refers to conditions that include coronary heart disease, cerebrovascular disease, peripheral artery disease and aortic atherosclerotic disease. These conditions may lead to heart attacks, bypass surgeries, stenting procedures, amputations and strokes.
The Veterans Affairs Lipid Optimization Reimagined Quality Improvement (VALOR-QI) program aims to improve the treatment of high cholesterol in veterans whose ASCVD puts them at high risk of recurrent heart attack or stroke. It will be implemented in 50 selected VA medical center sites and reach up to 30,000 veterans over three years, specifically focusing on veterans whose low-density lipoprotein cholesterol (LDL-C) remains at or above 70 mg/dl despite standard care. The program will take a multi-pronged approach designed to enhance the VA health system’s ability to identify high-risk patients, augment clinicians’ understanding of ASCVD treatment guidelines and their importance and educate veterans on how to manage their high cholesterol and seek appropriate care.
“Despite existing attempts to control cholesterol, there is still a significant population-level gap between what most ASCVD patients experience and what we believe is possible,” said Carolyn Clancy, M.D., assistant under secretary for health for Discovery, Education and Affiliate Networks at the VA. “Continuing variation by race, sex, ethnicity and socio-economic status compounds this gap. VALOR-QI aims not only to improve treatment for ASCVD, but also to redouble our efforts to find ways to overcome barriers to health equity for all veterans.”
The best methods of managing high cholesterol include modifying lifestyle factors such as diet and exercise, as well as using medication. The initiative seeks to provide a mixture of education, staff training, monitoring, health coaching, medication and other steps to achieve better compliance. Taking such a comprehensive approach will be the key to better managing cardiovascular disease and saving lives.
VALOR-QI builds off the American Heart Association’s Integrated ASCVD Management Initiative. Both the VALOR-QI program and the American Heart Association’s Integrated ASCVD Management Initiative are supported by Novartis Pharmaceuticals Corporation.
“We know elevated LDL-C is a major risk factor for atherosclerotic cardiovascular disease,” said American Heart Association Chief Executive Officer Nancy Brown. “This new program will help identify strategies to reduce cholesterol levels and improve health outcomes. VALOR-QI and American Heart Association’s overall Integrated ASCVD Management Initiative will ultimately help reduce the risk of heart disease and stroke for millions of people everywhere.”
Program lead Michael Gaziano, M.D., MPH, cardiologist at VA Boston Healthcare System, noted that while the health impact from lowering cholesterol is well-known, finding the right way to align clinical support for veterans to achieve this has remained an enduring challenge, which VALOR-QI aims to address. Gaziano oversees the national leadership team coordinating the program’s implementation at the 50 VA sites.
VALOR-QI participating sites will undergo rigorous evaluation using metrics designed to assess ASCVD management among patients. In addition, the VALOR-QI program will scrutinize existing disparities in ASCVD management, then develop and implement strategies to address health equity gaps by sex, race, ethnicity and other demographic variables.
“Cardiovascular disease is the No. 1 cause of death in the U.S., and it is also the leading cause of hospitalizations for our veterans in the Veterans Affairs health care system," said Victor Bulto, president of Novartis Innovative Medicines US. “Novartis is proud to support the American Heart Association and Veterans Health Administration in improving cardiovascular care and outcomes for veterans and building a foundation from which continued progress can be made.”
# # #
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
END
New program for veterans with high cholesterol, associated cardiovascular disease
The American Heart Association and Department of Veterans Affairs program will provide a blueprint for quality and care improvement, with support from Novartis Pharmaceuticals Corporation
2023-03-21
ELSE PRESS RELEASES FROM THIS DATE:
An integrated approach to cool: how evaporation and radiation can cool the world
2023-03-21
Large-scale, effective, and passive: these descriptions are aptly given to the integrated radiative and evaporative chiller (IREC), designed and tested by researchers at Tsinghua University in Beijing, China. The goal of this technology is to come up with an energetically affordable method of cooling to aid in the rising consumption of energy while still minimizing carbon emissions through the process.
“Energy scarcity is a universal challenge to global development. The demand for ...
TAMEST names MD Anderson’s Dr. Florencia McAllister recipient of the 2023 Mary Beth Maddox Award & Lectureship
2023-03-21
TAMEST (The Texas Academy of Medicine, Engineering, Science and Technology) has announced Florencia McAllister, M.D., The University of Texas MD Anderson Cancer Center, as the recipient of the 2023 Mary Beth Maddox Award and Lectureship in cancer research. She was chosen for her seminal discoveries at the intersection of microbes, the immune system and pancreatic cancer, leading to insights into early detection, prevention and therapeutic strategies to fight the disease.
The Mary Beth Maddox Award and Lectureship ...
Family Heart Foundation research finds high-risk Americans who do not maintain guideline recommend LDL-C targets have 44% higher rate of cardiovascular events
2023-03-21
SAN ANTONIO, March 21, 2023 – A real-world, retrospective analysis by the Family Heart Foundation, a leading non-profit research and advocacy organization, found that high-risk Americans who do not maintain levels of LDL-cholesterol (LDL-C) recommended in the 2018 American College of Cardiology/American Heart Association cholesterol treatment guidelines, had a 44% higher rate of cardiovascular events compared to those who did achieve and maintained recommended LDL-C levels. The study findings, which were based on data from the Family Heart DatabaseTM of more than 300 million Americans, will be ...
Forest growing season in eastern U.S. has increased by a month
2023-03-21
COLUMBUS, Ohio – The growing period of hardwood forests in eastern North America has increased by an average of one month over the past century as temperatures have steadily risen, a new study has found.
The study compared present-day observations of the time span from budburst to peak leaf coloration in seven tree species to similar documentation that was collected by an Ohio farmer at the turn of the 20th century.
An analysis of changes in those leaf patterns along with decades of temperature data for northwest Ohio showed a clear connection between increased warming during winter and spring and an extended period of tree growth.
The implications of the longer growing period – ...
How the "marsupial sabertooth" thylacosmilus saw its world
2023-03-21
A new study investigates how an extinct, carnivorous marsupial relative with canines so large they extended across the top of its skull could hunt effectively despite having wide-set eyes, like a cow or a horse. The skulls of carnivores typically have forward-facing eye sockets, or orbits, which helps enable stereoscopic (3D) vision, a useful adaptation for judging the position of prey before pouncing. Scientists from the American Museum of Natural History and the Instituto Argentino de Nivología, ...
Molecular teamwork makes the organic dream work
2023-03-21
The virus responsible for E. coli infection has a secret weapon: teamwork.
Always scrappy in its bid for survival, the virus alights on an unassuming host cell and grips the surface with the business end of its tubular tail. Then, the proteins in the tail contract in unison, flattening its structure like a stepped-on spring and reeling the virus's body in for the critical strike.
Thanks to the proteins' teamwork, the tail can flex and flatten with ease. This process, called molecular cooperativity, is often observed in nature but rarely ...
Wearable microscopes advance spinal cord imaging in mice
2023-03-21
LA JOLLA—(March 21, 2023) The spinal cord acts as a messenger, carrying signals between the brain and body to regulate everything from breathing to movement. While the spinal cord is known to play an essential role in relaying pain signals, technology has limited scientists’ understanding of how this process occurs on a cellular level. Now, Salk scientists have created wearable microscopes to enable unprecedented insight into the signaling patterns that occur within the spinal cords of mice.
This technological advancement, detailed in two papers published in Nature Communications ...
ACTG announces publication of pivotal hepatitis C study in Clinical Infectious Diseases
2023-03-21
Los Angeles, Calif. – The AIDS Clinical Trials Group (ACTG), the world’s largest HIV research network, is announcing the publication of “Perspectives on Adherence from the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach with 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment” in the journal Clinical Infectious Diseases. This publication found that self-reported 100 percent adherence in the first four weeks of hepatitis C treatment with sofosbuvir/velpatasvir was associated with sustained virologic response (which is when no hepatitis C virus is found in the blood 12 weeks after completing ...
Built environment strongest predictor of adolescent obesity, related health behaviors
2023-03-21
ROCKVILLE, Md.—New research shows that the built environment, not social and economic environments, is a strong predictor of adolescents’ body mass index (BMI), overweight and obesity status, and eating behaviors, according to a new study in Obesity, The Obesity Society’s (TOS) flagship journal. This study provides the first quasi-experimental empirical evidence of these environments on adolescents’ BMI, overweight, obesity and related behaviors.
“Our research suggests that strategies for addressing ...
The Minderoo-Monaco Commission on Plastics and Human Health issues sweeping new report
2023-03-21
Chestnut Hill, Mass (3/21/2023) – Philip Landrigan, MD, director of the Program on Global Public Health and the Common Good and the Boston College Observatory on Planetary Health, is the lead author of a groundbreaking new report about the far-reaching health hazards of plastics manufacturing and pollution across the entire product life cycle. Published in the journal Annals of Global Public Health and released in Monaco during Monaco Ocean Week, the study was undertaken by an international group of scientists ...
LAST 30 PRESS RELEASES:
Scientists unlock secrets behind flowering of the king of fruits
Texas A&M researchers illuminate the mysteries of icy ocean worlds
Prosthetic material could help reduce infections from intravenous catheters
Can the heart heal itself? New study says it can
Microscopic discovery in cancer cells could have a big impact
Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer
Breakthrough new material brings affordable, sustainable future within grasp
How everyday activities inside your home can generate energy
Inequality weakens local governance and public satisfaction, study finds
Uncovering key molecular factors behind malaria’s deadliest strain
UC Davis researchers help decode the cause of aggressive breast cancer in women of color
Researchers discovered replication hubs for human norovirus
SNU researchers develop the world’s most sensitive flexible strain sensor
Tiny, wireless antennas use light to monitor cellular communication
Neutrality has played a pivotal, but under-examined, role in international relations, new research shows
Study reveals right whales live 130 years — or more
Researchers reveal how human eyelashes promote water drainage
Pollinators most vulnerable to rising global temperatures are flies, study shows
DFG to fund eight new research units
Modern AI systems have achieved Turing's vision, but not exactly how he hoped
Quantum walk computing unlocks new potential in quantum science and technology
Construction materials and household items are a part of a long-term carbon sink called the “technosphere”
First demonstration of quantum teleportation over busy Internet cables
Disparities and gaps in breast cancer screening for women ages 40 to 49
US tobacco 21 policies and potential mortality reductions by state
AI-driven approach reveals hidden hazards of chemical mixtures in rivers
Older age linked to increased complications after breast reconstruction
ESA and NASA satellites deliver first joint picture of Greenland Ice Sheet melting
Early detection model for pancreatic necrosis improves patient outcomes
Poor vascular health accelerates brain ageing
[Press-News.org] New program for veterans with high cholesterol, associated cardiovascular diseaseThe American Heart Association and Department of Veterans Affairs program will provide a blueprint for quality and care improvement, with support from Novartis Pharmaceuticals Corporation